Eudaimonia Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.12M Sell
26,525
-77
-0.3% -$5.88K 0.5% 41
2023
Q4
$2.1M Buy
26,602
+227
+0.9% +$16.2K 0.55% 42
2023
Q3
$1.84M Sell
26,375
-265
-1% -$18.8K 0.45% 50
2023
Q2
$1.84M Sell
26,640
-317
-1% -$22.6K 0.41% 52
2023
Q1
$2M Sell
26,957
-2,266
-8% -$190K 0.48% 44
2022
Q4
$2.72M Sell
29,223
-148
-0.5% -$14.3K 0.67% 35
2022
Q3
$2.8M Sell
29,371
-434
-1% -$43K 0.73% 30
2022
Q2
$2.76M Buy
29,805
+2,282
+8% +$223K 0.51% 51
2022
Q1
$2.79M Buy
+27,523
New +$2.89M 0.47% 57
2021
Q3
$2.53M Buy
29,849
+1,079
+4% +$90.4K 0.46% 62
2021
Q2
$2.4M Buy
28,770
+3,710
+15% +$304K 0.45% 59
2021
Q1
$1.89M Buy
25,060
+721
+3% +$52.5K 0.39% 65
2020
Q4
$1.66M Buy
24,339
+6,366
+35% +$414K 0.37% 70
2020
Q3
$1.05M Buy
17,973
+4,762
+36% +$296K 0.27% 94
2020
Q2
$858K Sell
13,211
-320
-2% -$20.2K 0.33% 81
2020
Q1
$803K Buy
13,531
+171
+1% +$11.4K 0.35% 75
2019
Q4
$992K Buy
+13,360
New +$938K 0.39% 69

Other funds holding CVS

Eudaimonia Partners's CVS Position: Q1 2024 in Review

Eudaimonia Partners reduced its CVS Health (CVS) stake by 0.29% in Q1 2024, selling an estimated $5.88K and leaving 26,525 shares worth $2.12M. The position accounts for 0.5% of the portfolio, ranked #41.

Eudaimonia Partners first reported a position in CVS in Q4 2019 and has held it in 17 quarters since. The position peaked at $2.8M in Q3 2022. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Eudaimonia Partners held 26,525 shares of CVS Health worth $2.12M as of Q1 2024.
  • Eudaimonia Partners sold 77 CVS Health shares in Q1 2024, an estimated $5.88K.
  • CVS Health made up 0.5% of Eudaimonia Partners's portfolio in Q1 2024, its #41 holding.
  • Eudaimonia Partners first reported a position in CVS Health in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's CVS Health position peaked at $2.8M in Q3 2022.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.